Blog
Central Garden (CENTA) Reports Q4 Loss, Tops Revenue Estimates
Central Garden (CENTA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures
Central Garden (CENT) Reports Q4 Loss, Beats Revenue Estimates
Central Garden (CENT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures
Woodward (WWD) Q4 Earnings and Revenues Beat Estimates
Woodward (WWD) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.41 per share a year ago. These figures
Blue Bird (BLBD) Surpasses Q4 Earnings and Revenue Estimates
Blue Bird (BLBD) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.77 per share a year ago. These figures
Top Stock Reports for Alphabet, Roche & RTX
Monday, November 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet
Buffett Loves Japan. Should You?
- (0:50) - What Should Investors Know About Japan's New Prime Minister And Their Policies
- (6:25) - What Is Currently Driving Japan’s Equity Rally?
- (13:00) - ETFs Investors Should Consider When
Top Stock Picks for Week of November 24, 2025
Apple’s (AAPL) business primarily runs around its flagship iPhone. Apple is benefiting from strong growth in Services revenues. The company now has more than 1 billion paid subscribers across its
Strategy Shares Slide 41% YTD: Is Holding the Best Move Now?
Strategy MSTR shares have plunged 41.1% year to date (YTD), underperforming the broader Zacks Finance sector’s growth of 11.3% and the Zacks Financial- Miscellaneous Services industry’s decline of
BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study
Bayer AG BAYRY announced that pipeline candidate asundexian met primary efficacy and safety endpoints in late-stage OCEANIC-STROKE Study in secondary stroke prevention.
Results from the study showed
JBLU Expands Gateway Program to Build Aircraft Maintenance Workforce
JetBlue Airways' JBLU proactive, strategic initiative to secure the next generation of technical talent comes through the launch of Gateway University – Tech Ops. With this move, the airline is not
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
3 Reasons Growth Investors Will Love McKesson (MCK)
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
3 Reasons Why Growth Investors Shouldn't Overlook Alarm.com (ALRM)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
3 Reasons Growth Investors Will Love Newmont (NEM)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Here is Why Growth Investors Should Buy Addus HomeCare (ADUS) Now
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth
Is Agilysys (AGYS) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't
Looking for a Growth Stock? 3 Reasons Why Epam (EPAM) is a Solid Choice
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock
Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
ANET Gains From Solid Revenue Growth: Will the Uptrend Continue?
Arista Networks, Inc. ANET is witnessing solid revenue growth backed by solid customer wins and robust portfolio strength. In the third quarter, the company’s revenues surged to $2.31 billion from



